Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer - results from the phase III OVHIPEC trial". Koole SN, Schouten PC, van Driel WJ, Sonke GS, et al. Int J Cancer 2022 Jul 20. doi: 10.1002/ijc.34219.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koole SN, Schouten PC, van Driel WJ, Sonke GS, et al. Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer - results from the phase III OVHIPEC trial". Int J Cancer 2022 Jul 20. doi: 10.1002/ijc.34219.
PMID: 35857410